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Although  one  characteristic  of  a  virus  is  its  possession  of  immunological 
specificities different from those of its host  (1)  the finding of a  new specificity 
in the tissues of a  diseased animal may reflect changes brought about by the 
virus, and  so not  indicate  the virus itself  (2).  The distinctive  specificity of a 
virus is, moreover, not necessarily absolute.  Frequent  instances  of the occur- 
rence  of  the  specificities  of  normal  tissue  in  virus  preparations  have  been 
noted and  some of these have been studied  by quantitative immunochemical 
techniques  (3, 4). The capacity for neutralization by specific antibodies is also 
characteristic of viruses, in common with other biologically active antigens. 
Because of its immunological and biological characteristics the factor in mouse 
milk connected with mammary carcinoma has been considered to be a  virus. 
The factor was shown  to stimulate  the  production  of neutralizing  antibodies 
(5,  6)  and, on the basis of parallel experiments with antisera to tissue extracts 
containing the factor and with antisera to normal mouse tissues it was stated 
(6) that the "agent is antigenically different from mouse tissue and not derived 
therefrom." This  has  also  been indicated  by qualitative  precipitin  tests  (7). 
The  present  investigation  was  undertaken  (a)  because  of  continuing  uncer- 
tainties as to the viral nature of the factor,  (b) because quantitative immuno- 
chemical data exist for relatively few viruses which are pathogenic for animals 
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(3,  4),  and (c)  because  of  the great  importance  of immunological  specificity in 
the study  of the nature  of incitants to cancer. 
Materials and Methods 
Milk Factor.--Highly  purified preparations of  the mouse milk  factor  (hereinafter desig- 
nated as F) have been reported by several groups of investigators (8, 9).  The material used 
in the present studies was prepared from Paris RIII  strain milk  according to the method of 
Graft et al. (8). 
Mouse milk was also obtained from normal animals of the C57  strain. Mter centrifugafion 
at low speed in the cold and removal of much fat  (fraction C) the skim milk was centrifuged 
for 1 hour at 10,000 lt.p.~, in the chilled rotor of a Servall centrifuge. The white sediment was 
designated fraction A and the clear milk serum fraction B. Fraction A  was washed once with 
safine containing 0.02 to 0.05 ~a CaC12 and 1:10,000 merthiolate and was then taken up in the 
same solvent. At least two different proteins, separable with the help of Na2SO4, were present 
in fraction B, but ordinarily the mixture was  used both for the injection of rabbits and for 
the absorption of sera. 
Extract of Normal Mouse Breast Tissue.--Normal C57  non-lactating mice were exsangui- 
nated and breast tissue was excised from 28 animals by Dr. H.  T. Randall and allowed to 
stand in a CO2 refrigerator overnight. After addition of 10 ml. of cold saline and 10 ml. of 1.2S 
per cent NaHCO3 solution the thawed tissue was rapidly comminuted in the cold in a Waring 
blendor with  a  small  metal  mixing chamber.  Low  speed  centrifugation removed  fat  and 
large particles. The turbid pink solution was run through a folded filter several times in the 
cold and was finally allowed to drip into toluene. The mixture was centrifuged in the cold 
and the aqueous layer again filtered, remaining opalescent. 1 per cent by volume of 1 per cent 
merthiolate  1 solution was added. 
Immunization  of Rabbits.--After a  preliminary bleeding designated by the subnumeral 0, 
rabbits MF 1 and 3 were each given 7 intravenous injections totalling 10 rag. of F in the course 
of 9 days and were bled 6 days later (bleedings 11 and 31). 4 weeks later a similar course of 10 
injections totalling 17 mg. F  was given and the rabbits were bled 6 days later (bleedings 12 
and 32). 
A suspension of F  containing 22 mg. in 2.5 ml. was homogenized in a mortar with 2.5 ml. 
of aquaphor and 5 ml. of paraffin oil containing 6.25 rag. of dry tubercle bacilli (i0). Threa 
1 ml. portions of the mixture were injected intramuscularly at weekly intervals into rabbits 
MF 7, 9, and 10. Bleedings were taken 10 days, 1 month, 2 months, and in the case of Nos. 
9 and 10, 3½ months, after the third injection. In this series each rabbit received a  total of 7 
rag. of F. 
Similarly, 4 ml. each of C67 milk fractions A and B, containing 96 and 56 rag. of protein, 
respectively, were mixed with 9.4 mg. of dry tubercle bacilli, 4 ml. of aquaphor, and 8 ml. of 
paraffin oil. Two rabbits, MM 1 and 2, were given three intramuscular injections of approxi- 
mately 1 ml. of mixture A at weekly intervals and two rabbits, MM 3 and 4, were given simi- 
lar injections of mixture B. The amounts of protein injected were approximately 18 and 10 
rag., respectively. Bleedings were taken 12 days,  1 month, and 1] months after the last in- 
jection. 
Analyses  of Antisera.--Purified  lots of F  were taken up in a  small volume of saline and 
diluted to contain about 100 to 150/~g. N  per 0.2 ml. Merthiolate was added to a  final con- 
centration of 1:10,000. Usually 0.20 ml. of the solution was added in duplicate to 0.50 or 1.0 
ml. samples of anti-F serum diluted with 1 ml. of saline in tapered pyrex centrifuge tubes of 
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7 to 8 ml. capacity (11). A serum blank was also run, but F  blanks were discontinued when 
it was found that negligible quantities of N  remained in the tubes after the usual centrifu- 
gations and washings according to (11,  12). Most of the anti-F sera precipitated rapidly upon 
mixing with F. In such instances the number of absorptions necessary for precipitation of all 
of the antibody could be reduced by adding a  second portion of F  before allowing the mix- 
tures to stand 48 hours in the cold.  After centrifugation the supernatants were transferred 
quantitatively to a new set of tubes and the analyses were repeated, numerous absorptions of 
a  serum  occasionally being found necessary.  If,  after centrifugation, the supernatants and 
washings were entirely clear and thus showed no evidence of uncombined F, the entire amount 
of F  nitrogen added was subtracted from the total N  found by the micro-Kjeldahl or Mark- 
ham (13) method. The former procedure was preferred for precipitates containing more than 
TABLE I 
Successive Absorptions of Rabbit Antiserum to Mouse Milk Factor with Homologous Antigen 
Sei'nnl No. 
Pool  7x,  91  absorbed 
with C57 milk frac- 
tion B  (Table II) 
7a, 91 unabsorbed 
VoL 
anti- 
$¢rnm 
dilution 
ml. 
2.5 
0.5 
hnount  Total 
mtigen  preci[ 
itrogen  tate~ 
~g.  /~g. 
101  246 
51  106 
303  558 
101  158: 
101  117 
101  81 
101  205 
101  113 
51111  18 
~ody 
precipi- 
tated 
t~g. 
145 
55 
255 
57 
29~ 
20I 
104 
34§ 
5I 
Ratio 
mtibody 
N: anti- 
gen N  in 
precipi- 
tate 
1.4 
1.1 
0.8 
0.6 
1.0 
Appearance of 
supernatants or 
washings 
Clear 
Slightly opalescent 
Opalescent 
Clear 
* One determination lost. 
~: Total N  -- 4, on basis of decreasing antibody:antigen ratios. 
§ Total N  :-- 3, on basis of previous ratio 
][ Superuatants combined and 101 #g. antigen N added. 
150 #g. N.  Usually after the first or second precipitation the supernatants and/or washings 
showed a sfight turbidity. Although this was possibly due to antigen-antibody complexes, for 
simplicity the turbidity was assumed to be caused by excess F. The composition of any pre- 
cipitate remaining in the tubes after washing was then calculated as in the examples given in 
Table I, under the assumption of a regular diminution in the values of the antibody N: antigen 
N  ratios found in the preceding absorptions of the serum. While the necessity of calculating 
the amount of antibody precipitated in the final absorptions introduces an uncertainty into 
the total values found, it is believed that the method used ensures figures that are too low 
rather than too high. 
Addition of amounts of F  solution varying between 0.05 and 0.2 ml. resulted in the pre- 
cipitation of minimal quantities of N  from normal rabbit sera or from antisera to the fractions 
of C57 mouse milk. 
Quantitative analyses of antisera with fraction A of C57 milk gave uncertain results, partly 
because this fraction required prolonged centrifugation at high speed and partly because its 
solubility in sera increased with increasing pH. The data obtained even after neutralization of TABLE II 
l~recipilation  by  Fractions  of C57 Mous,  Milk  (A,  B)  and  by Milk  Factor  (F) in  Antisera 
to Mouse Milk Factor 
Data calculated to 1.0 ml. undiluted serum. 
Anti-  Anti-  Third  Anti-  Fourth  body N  Antibody N  Second  body N  body N  antigen  Rabbit serum  Antigen  antigen  • •  antigen  precipi-  precipi. 
preclpl-  added  added  Nos.  precipitated  added  tated  tatod  rated 
t~g.  pg. 
MF1,  110 F 
12  110  F 
A 
110 F 
A 
110 F 
113 B 
Ct§ 
3x 
32 
111 F  1264 
NBT~t  5*  111 F  116  'l 
NBT  0  111 F  223  s 
Normal pool  A  110 F  5 
"  "  70, 90  B 
71, 91  A  8 
B 
110 F 
72  B ~ 
111 F 
73  112 F 
9,  A  s 
lag.  ~g. 
89  e 774 
119  e  21" 
131" 
176  e 
4  39* 
2797  20* 
974*  t 
1' 
15]1  ~  ca 2* 
>2* 
14" 
21"  I0)  263  e 
2943 
72*  0* 
4947 
328e;  after  inactivation 
351l  B6  39* 
1354  I 
1684 
804 
2 
112, 3 1065 
74*  A  I 
94,3  95  ~  ] 
90,s  663  [ 
28,  a  22  a 
109 F  2644 
93 
% 
100 
lOz 
10~ 
lOs 
I04 
110 F 
112 F 
112 F 
111 F 
Ill F 
111 F 
111 F 
111 F 
111 F  ¶ 
at  56°C.,  262 
110 F  95  ~** 
NB'P  7* 
;3  1" 
111 F  100  s 
i10 F  1258 
Superscripts denote number of absorptions. 
* Total N. 
:~ Extract of C57 mouse breast tissue. 
§ Crystalline chymotrypsin, 4.4/~g. N. 
[I Run in triplicate, suspension of A washed three times. 
¶Unstable solution of A used; precipitated during absorption of serum with F. 
** After another absorption with A and 3 more with B, 83 #g. of antibody N were precipi- 
tated by 111 F. The serum had by this time been diluted seven-fold. 
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several sera are therefore omitted. An actual solution of fraction A, made from a suspension 
with a little NaHCO~, was scarcely more helpful. Although the solution gave a small specific 
precipitate  with an antiserum to fraction A and yielded no appreciable precipitate with anti-F, 
a  considerable proportion of~ the protein precipitated on standing, so that quantitative data 
on residual antibodies in the anti-F serum and on absorptions of other sera were invalidated. 
Anti-F sera were, however, absorbed several times with suspensions of fraction A, as noted 
in Table II, in order to remove, if possible, any antibodies to this fraction. It has recently been 
found that phosphate solutions of fraction A are more stable than those prepared with bi- 
carbonate. 
Since fraction B was known to be heterogeneous, values of total N  precipitated are g~ven 
for analyses with this material. In most instances far less N was precipitated than was added, 
particularly in the final absorptions of anti-F sera in which several milliliters of 1 to 2 per 
cent solutions of fraction B were added. 
Chymotrypsin  and Antisg'a to Ckymotrypsin.--Since chymotrypsin (Ct) was  used  for the 
digestion of mouse milk proteins in the preparation of F (8) it was considered advisable to de- 
termine whether or not any new specificity shown by F might be due to Ct. With the help of 
adjuvants (10) as above a precipitating antiserum was obtained in a rabbit. This serum gave 
no precipitate with F, nor did Ct precipitate appreciable quantities of N from an anti-F serum 
(Table II). 
DISCUSSION 
The experiments described in the preceding section and summarized in the 
tables show clearly that the mouse milk factor  (F) isolated from Paris R  III 
strain milk according to  the  method  of  Graft et  al.  (8),  is a  potent  antigen. 
Precipitating antisera were readily obtained with as little as 10 to 17 mg. of F 
when this was injected intravenously in multiple doses, and with 7 mg.  when 
F  was  mixed with  aquaphor  and  tubercle bacilli (10)  and  divided into  three 
portions which were given intramuscularly at weekly intervals. With the latter 
procedure peak antibody levels, in one instance as much as 0.5 rag. of antibody 
nitrogen per ml., were attained in from 10 to 30 days and fell off quite rapidly, 
possibly on account of the small quantity of antigen used. 
Presumably because of a  particle weight estimated roughly at 300  X  10  s, 
and  possibly also  because  the  preparations were  not  entirely pure  (8),  rela- 
tively large  quantities  of  F  were  required  to  absorb  the  antibody from  the 
stronger anti-F sera.  Under  the assumption  that all of the  F  nitrogen added 
was  precipitated  as  long  as  antibody  remained  and  the  supernatants  and 
washings were clear, the antibody N: antigen N  ratios in the precipitates were 
low  and  often  less  than  1,  reversing  the  usual  trend  with  smaller  antigens 
(Table I). 
Further details of the reaction between F  and homologous antibody will be 
given in another communication, since the main object of the present study was 
to  determine whether  or not  F  possessed a  specificity distinct from  those  of 
the  proteins  of mouse  milk  or  was  different from  the  proteins  of mammary 
tissue from which milk is secreted. 
For this purpose the fat was skimmed from the milk of normal C57 mice, which does not 
contain F, and the proteins were roughly divided into two fractions, one, A, centrifugable  in 
the Servall centrifuge at 10,000 R.P.~. and obviously consisting in large measure of casein, the 338  ]?ACTOR  IN  MILK  CONNECTED WITH  MAMMARY CARCINOMA 
other, B, the remaining proteins in the supernatant milk serum. Antisera in rabbits were ob- 
tained to these two fractions, although the anti-A sera were very weak. Anti-F sera were also 
exhaustively absorbed with suspensions of A, and with solutions of B  in increasing volume 
until no further evidence of precipitation could be obtained. 
The amounts of precipitate formed in  the anti-F  sera and  the numbers of 
absorptions  are  given  in  Table  II.  Unfortunately,  accurate  analytical  data 
could  rarely be  obtained  with  A,  even when  the  sera  were  brought  to  pH 
6.7-6.8 and the suspensions of A  were sufficiently coarse to sediment readily 
at 2,000 to 3,000 I~.P.M. in the No. 2 International  refrigerated centrifuge. In 
no instance was agglutination of A particles observed, nor, in the one case in 
which a  soluble preparation of A  was used after absorption with B, was any 
specific precipitate formed in the best of the antisera. Unfortunately, estimation 
of residual anti-F was vitiated in this instance by the instability of the solu- 
tion of A, which began to precipitate during subsequent analyses both in the 
presence and absence of this serum and others. In general, the anti-F sera gave 
more precipitate with  B  than  did normal rabbit  sera,  but the nitrogen  pre- 
cipitated  appeared  to  come only in part  from the  anti-F  content.  This was 
shown both by the high proportion of anti-F remaining even after numerous 
absorptions with B, and by the appreciable precipitates obtained with B after 
several  sera  were  first  precipitated  exhaustively  with  F  (for  example,  sera 
12 and 32, Table II).  The extract of C57 mouse breast tissue,  in amounts of 
0.2 to 1.5 ml., containing 116 to 870 gg. of N, respectively, failed to yield appre- 
ciable precipitates in anti-F sera, nor did the presence of this material, which 
must have contained serum proteins as well as tissue proteins, inhibit precipi- 
tation of most of the anti-F present in the original serum. 
It is also evident that the specificity of F  is unrelated to that of the chymo- 
trypsin used in its preparation, as the enzyme gave practically no precipitate in 
serum 3~, containing 279 ~g. of anti-F N  per ml. (Table II) and F  precipitated 
only 2 gg. N  from an antiserum to chymotrypsin which yielded a total of 190 
/~g. of precipitable N  with 31 #g. of enzyme N. 
As noted in Table III,  precipitation of F  in  anti-B  sera  is  very slight,  so 
that there is no marked cross-reaction in this direction. Since there was little 
antibody in  the  anti-A  sera  attempts  are  now  being made  to  obtain  better 
sera. 
While  the data  assembled  in  the present study supply additional  evidence 
that the mouse milk factor shows an immunological specificity different from 
those of normal mouse proteins (6,  7)  the evidence is not yet conclusive. The 
necessity for the use of another strain of mice as a  source of factor-free milk 
and tissue proteins raises the question as to whether or not a  closer relation- 
ship  would  have been found  had  it  been possible  to  use  material  from  the 
homologous strain. Not only must extracts of other mouse tissues and organs 
be tested against antisera to F, but before one can assert with assurance that 
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C57  milk  in  appreciable amount  it  will  be  necessary  to  obtain  more  stable 
solutions of the milk fraction A and stronger antisera to this fraction. However, 
the  indications  thus  far  point  to  very  little  cross-reactivity  between  this 
fraction and  F. The  cross-reactivity between  F  and  fraction B  of C57  mouse 
TABLE III 
Reactions  of C57 Mouse Milk Fractions  and  Mouse Milk Factor in Antisera to 
Fractions  of C57 Mouse Milk 
Calculated to 1.0 ml. undiluted serum. 
Rabbit serum  Antigen  Antibody N  Second antigen  Total N  Third antigen  Total N 
Nos.  precipitated  added  precipitated  added  precipitated 
~g.  #g.  /;g. 
Antisera to fraction  A 
NM 10 
11 
ls 
20 
2~ 
110 F 
110 F 
F 
A 
B 
F 
B 
A 
F 
B 
A 
43 
13 ~ 
42 
21" 
9** 
0 
0 
? 
23 
30** 
? 
B 
NBT 
B 
+ 
0 
13" 
A 
A 
Antisera to fraction B 
3o 
31 
3, 
40 
41 
4~ 
F 
B 
F 
B 
B 
F 
B 
F 
B 
B 
0 
0 
4 a 
81 ~* 
964* 
0 
0 
86 
446* 
38** 
* Total N. 
milk is more  extensive although  not  all of the precipitate would seem due  to 
antibody to F, as explained above. In some anti-F sera 5 to 10 rag. of B  sufficed 
for complete absorption with this fraction, but in others up to 5  to 6  volumes 
of  1  to  2 per cent solutions were necessary. In all cases, however,  more than 
one-half of the original anti-F was still precipitable in the supernatant, and often 
nearly as much as in the unabsorbed sera. It is evident, therefore, that F  differs 
from any protein present in fraction B  in appreciable amount.  F  is, moreover, 340  ]?ACTOR  IN MILK CONNECTED WITH MAMMARY CARCINOMA 
unlike influenza virus in this respect, for the preparations of influenza particles 
studied quantitatively (3, 4) appeared to contain a specificity of normal chick 
embryo tissue and completely exhausted antisera to chick embryo. The em- 
P 
bryo did not, however, exhaust anti-viral sera. 
Work  along the  above  lines  is  being  continued and  other  studies  on  the 
immunochemical relationships of F  such as the neutralization of F  by known 
quantities of antibody N, are being carried out. 
SUMMARY 
Antisera to the mouse milk factor (F), containing up to 0.5 mg. of antibody 
nitrogen per ml. are readily obtainable in rabbits,  especially when adjuvants 
are added to the antigen. 
Quantitative data on the anti-F content of the sera are given, also on the 
total nitrogen precipitated by the non-casein fraction of C57 mouse milk which 
does not contain F. 
The antisera were also absorbed with casein fractions but the diificulties in 
the way of quantitative analysis were not overcome. 
Antisera to fractions of C57 mouse milk were also obtained and the reactions 
of F  and the C57 proteins with these sera were studied. 
The results, as far as they go, are in accord with the earlier belief that the 
milk factor possesses an immunological specificity not present in normal mouse 
tissues. 
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